UroGen Pharma says permanent J Code for ZUSDURI now in effect [Yahoo! Finance]
Urogen Pharma (NASDAQ:URGN) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $33.00 price target on the stock.
Permanent J Code for ZUSDURI™ Now in Effect, Expanding Patient Access to Innovative Bladder Cancer Therapy
Loss-Making UroGen Pharma Ltd. (NASDAQ:URGN) Expected To Breakeven In The Medium-Term [Yahoo! Finance]
Billionaire Family Office Dumps All of Its UroGen Stock Amid 100% Rally [Yahoo! Finance]